Comprehensive information about experimentally validated enhancers
| Enhancer ID: | E_04722 |
| Species: | Homo sapiens |
| Position : | chr6:28895115-28896348 |
| Year: | 2023 |
| Title: | High-sensitive nascent transcript sequencing reveals BRD4-specific control of widespread enhancer and target gene transcription. |
| Genome Build: | hg38 |
| Enhancer Type: | Enhancer |
| Condition: | Normal |
| PMID: | 37591883 |
| Tissue: | blood |
| Tissue Ontology ID: | UBERON:0000178 |
| Cell Source: | K-562 |
| CVCL ID: | CVCL_0004 |
| Cell Type: | hematopoietic leukemia-derived cell |
| Experiment Type: | Enhancer discovery; Nascent-transcription regulation assay; Reporter-validation panel |
| High Throughput Method: | HiS-NET-seq; BRD4 ChIP-Rx; GRO-cap; H3K27ac/H3K4me1 chromatin integration |
| Low Throughput Method: | Sense/antisense dual-luciferase reporter panel; candidate retained as candidate until construct-number/activity mapping is attached |
| Target gene : | NA |
| TF name : | NA |
| Regulatory State : | Active |
| GeneName | Pathway Name | Source | Gene Number |
|---|